Literature DB >> 9719122

The role of radiation therapy in the management of sialorrhea.

M Borg1, F Hirst.   

Abstract

PURPOSE: Sialorrhea is the unintentional loss of saliva and other contents from the mouth. Most patients with this condition are elderly, requiring palliative treatment. These patients have neuropathology with associated poor performance status. Treatment prescribed for this disabling and distressing condition has often been of a surgical nature and described in young patients. It would be inapplicable to the elderly. The aim of this study was to review the role of radiation therapy in the management of sialorrhea. Previous reports are few in number and are cautionary because of adverse effects which have been described, including dryness of the mouth. METHODS AND MATERIALS: A total of 34 patients were referred to the Department of Radiation Oncology, Palmerston North Hospital, between 1966 and August 1994, of whom only 1 patient received treatment prior to 1985. Three patients declined treatment and were, therefore, excluded from this review. Thirty-one patients, including 14 males and 17 females, of median age 72 years received 1 or more radiation treatments for sialorrhea. The patients were followed up for a median of 12 months, ranging from 6 months to 27 years.
RESULTS: Initially, 82% (28/34) of treatments were associated with a satisfactory response. Six patients relapsed, of whom five experienced relapse within 6 months of initial treatment. Two patients were re-treated, one of whom achieved a complete response. Up to the time of review 64% (23/36) of treatments maintained a satisfactory response. The varied fractionation regimens used were not shown to affect the response rate; low doses were shown to be as effective as higher doses, and were not associated with any significant acute or late side effects. Only 4 patients developed long-term side effects. However, response rates were superior for patients treated with electrons, as opposed to orthovoltage therapy, and in particular when electron energies greater than 7 megavolts were used (76% vs. 38% maintained response, p < 0.05). Responses were also superior for patients treated with radiation fields which encompassed both parotid and submandibular glands (74% vs. 33 % maintained response, p < 0.01).
CONCLUSIONS: Radiation therapy has proven to be a safe and effective treatment in this group of patients, thereby avoiding the adverse effects of anticholinergic medication and invasive surgical procedures.

Entities:  

Mesh:

Year:  1998        PMID: 9719122     DOI: 10.1016/s0360-3016(98)00153-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  [Drooling following radiation. Botulinum toxin as a successful treatment modality].

Authors:  A Steffen; B Wollenberg; R Schönweiler; N Brüggemann; T Meyners
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

Review 2.  Hypersalivation: update of the German S2k guideline (AWMF) in short form.

Authors:  Armin Steffen; Wolfgang Jost; Tobias Bäumer; Dirk Beutner; Sabine Degenkolb-Weyers; Martin Groß; Maria Grosheva; Samer Hakim; Kai G Kahl; Rainer Laskawi; Rebekka Lencer; Jan Löhler; Thekla Meyners; Saskia Rohrbach-Volland; Rainer Schönweiler; Sara-Christina Schröder; Sebastian Schröder; Heidrun Schröter-Morasch; Maria Schuster; Susanne Steinlechner; Roland Urban; Orlando Guntinas-Lichius
Journal:  J Neural Transm (Vienna)       Date:  2019-04-10       Impact factor: 3.575

3.  Botulinum toxin in the treatment of drooling in tetraplegic patients with brain injury.

Authors:  Sung Hwa Ko; Yong Beom Shin; Ji Hong Min; Myung Jun Shin; Jae Hyeok Chang; Yong-Il Shin; Hyun-Yoon Ko
Journal:  Ann Rehabil Med       Date:  2013-12-23

Review 4.  Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management.

Authors:  Marcelo Merello
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

5.  [Radiotherapy : an option for refractory salivary fistulas].

Authors:  H Christiansen; H A Wolff; J Knauth; A Hille; H Vorwerk; C Engelke; R Rödel; R Laskawi
Journal:  HNO       Date:  2009-12       Impact factor: 1.284

Review 6.  Disorders of the oral cavity in Parkinson's disease and parkinsonian syndromes.

Authors:  Yair Zlotnik; Yacov Balash; Amos D Korczyn; Nir Giladi; Tanya Gurevich
Journal:  Parkinsons Dis       Date:  2015-01-15

Review 7.  Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Magí Farré
Journal:  Int J Med Sci       Date:  2015-09-22       Impact factor: 3.738

Review 8.  Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.

Authors:  Amanda Amrita Lakraj; Narges Moghimi; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2013-05-21       Impact factor: 4.546

9.  Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.

Authors:  Domenico A Restivo; Mariangela Panebianco; Antonino Casabona; Sara Lanza; Rosario Marchese-Ragona; Francesco Patti; Stefano Masiero; Antonio Biondi; Angelo Quartarone
Journal:  Toxins (Basel)       Date:  2018-01-27       Impact factor: 4.546

Review 10.  Therapy of Sialorrhea with Botulinum Neurotoxin.

Authors:  Wolfgang H Jost; Tobias Bäumer; Rainer Laskawi; Jaroslaw Slawek; Björn Spittau; Armin Steffen; Martin Winterholler; Ganesh Bavikatte
Journal:  Neurol Ther       Date:  2019-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.